UAE Blood Glucose Monitoring Devices Market to grow with a CAGR of 8.24%

Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the UAE Blood Glucose Monitoring Devices Market.

According to TechSci Research report, “UAE Blood Glucose Monitoring Devices Market Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, UAE Blood Glucose Monitoring Devices Market has valued at USD 0.14 billion in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 8.24% through 2028. This can be due to collaborations and partnerships among leading companies with a diverse approach to merge the expertise of individual companies and to strengthen their position.

Preventive healthcare practices contribute significantly to the demand for Blood Glucose Monitoring Devices (BGMDs). Preventive healthcare focuses on early detection of health issues to facilitate timely intervention. BGMDs play a crucial role in the early detection of changes in blood glucose levels, allowing for proactive management and the prevention of diabetes-related complications. Preventive healthcare encourages individuals to undergo regular screenings and risk assessments. BGMDs are valuable tools for assessing blood glucose levels, especially for those at risk of developing diabetes. This aids in identifying individuals who may need lifestyle modifications or closer monitoring. Preventive healthcare practices promote healthy lifestyles, including maintaining a balanced diet and engaging in regular physical activity. BGMDs support these practices by providing real-time feedback on the impact of lifestyle choices on blood glucose levels.

BGMDs enable individuals to adopt personalized preventive strategies based on their unique health profiles. Regular monitoring allows for the adjustment of diet, exercise, and medication, helping individuals tailor preventive measures to their specific needs. BGMDs contribute to overall health and wellness monitoring by providing insights into how lifestyle choices impact blood glucose levels. This holistic approach aligns with preventive healthcare goals of maintaining optimal health.

Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " UAE Blood Glucose Monitoring Devices Market”

In February 2023, EOFlow Co., Ltd. has announced the official launch of its tubeless, wearable, and disposable insulin pump, the EOPatch, in the United Arab Emirates (UAE) through its GCC partner, GulfDrug LLC. This marks the first introduction of EOPatches in the Middle East, establishing the UAE as EOFlow's second overseas sales region after Europe. The company anticipates the UAE to serve as a strategic gateway for exporting wearable insulin pump solutions to countries in the Middle East and North Africa (MENA). The EOPatch Insulin Management System, featuring a tubeless, wearable, and disposable design, utilizes a dedicated controller called ADM or a smartphone app named Narsha for continuous insulin delivery, offering an alternative to conventional insulin administration methods. The patch's user-friendly, wearable design allows up to 84 hours of continuous insulin delivery, enabling a twice-a-week replacement cycle and improving user compliance.

The challenge of integration with healthcare systems in the UAE Blood Glucose Monitoring Devices (BGMDs) Market reflects the broader issue of interoperability within healthcare infrastructure. The healthcare system in the UAE, like in many other regions, can be fragmented, with different healthcare providers, clinics, and hospitals using diverse electronic health record (EHR) systems. Achieving seamless integration across these varied systems can be challenging. Standardization of data formats and communication protocols is essential for smooth integration between BGMDs and healthcare systems. The absence of standardized practices can hinder the sharing and exchange of crucial patient data. Healthcare data, especially sensitive information like blood glucose levels, requires robust security measures. Integrating BGMDs with healthcare systems must comply with strict data security and privacy regulations, which may vary across different healthcare institutions.

UAE Blood Glucose Monitoring Devices Market is segmented based on Product Type, Application, End User, and by region.  

Based on the Application, UAE Blood Glucose Monitoring Devices Market is segmented into Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes. Gestational diabetes is a type of diabetes that occurs during pregnancy. This condition is characterized by elevated blood sugar levels that develop for the first-time during pregnancy, typically around the second or third trimester. While it often resolves after childbirth, gestational diabetes can pose risks to both the mother and the baby if not properly managed. Gestational diabetes is not present before pregnancy but develops during the gestational period. It is usually diagnosed between the 24th and 28th weeks of pregnancy through routine screening tests. Pregnancy naturally induces some degree of insulin resistance in the body. In gestational diabetes, this resistance is more pronounced, leading to an inability of the body to use insulin effectively, resulting in elevated blood sugar levels. Certain factors increase the risk of developing gestational diabetes, including being overweight, having a family history of diabetes, being older than 25, belonging to certain ethnic groups (such as Hispanic, African American, Native American, or Asian), and having previously given birth to a baby weighing over 9 pounds.

Based on Region, Abu Dhabi region held the largest share in the UAE Blood Glucose Monitoring Devices Market. Government policies and initiatives aimed at promoting healthcare, diabetes management, and the use of advanced medical technologies can influence market dynamics. Abu Dhabi has specific programs supporting blood glucose monitoring, it may lead to market dominance. Regions with higher awareness about diabetes and the importance of monitoring may see a greater demand for blood glucose monitoring devices. Abu Dhabi has effective awareness and education programs; it could contribute to market dominance. The region's ability to form strategic partnerships with healthcare device manufacturers and suppliers may play a role in its dominance. Access to the latest technologies and partnerships with key players can drive market growth.

Some of the major companies operating in the UAE Blood Glucose Monitoring Devices Market include:

• Abbott Laboratories SA
• Roche Diagnostics Middle East FZCO
• Johnson & Johnson Middle East FZ-LLC
• Medtronic Meta FZ-LLC
• Becton, Dickinson, and Company UAE
• Nipro Middle East FZE
• B. Braun Medical Gulf FZ-LLC

Download free Sample Report

Customers can also request 10% free customization on this report

“Certain areas, particularly in Dubai, are projected to exert significant demand for Blood Glucose Monitoring Devices. The growth in the competitive landscape and the presence of well-established companies in the market, committed to enhance the overall wellbeing of people each year, are expected to contribute to a remarkable growth of the UAE Blood Glucose Monitoring Devices Market in the forecast period," said Mr. Karan Chechi, Research Director with TechSci Research, a research-based Global management consulting firm.

UAE Blood Glucose Monitoring Devices Market by Product Type (Self Blood Glucose Monitoring Devices {Glucometers, Test Strips, Lancets}, Continuous Glucose Monitoring Devices {Sensors, Transmitters & Receivers, Integrated Insulin Pumps}), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By End User (Home Care Settings, Hospital, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F has evaluated the future growth potential of UAE Blood Glucose Monitoring Devices Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in UAE Blood Glucose Monitoring Devices Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com